Treatment of Attention-Deficit/Hyperactivity Disorder With Stimulants: Reducing Harms
Summary
Recent increases in ADHD diagnoses and stimulant-related harms, including overdose deaths, necessitate clinical strategies for harm reduction. This article addresses safe stimulant use and management in ADHD treatment.
Area of Science:
- Psychiatry
- Public Health
- Pharmacology
Background:
- Rising attention-deficit/hyperactivity disorder (ADHD) diagnoses since 2020.
- Concerns over prescription stimulant shortages and increased overdose deaths.
- Stimulants are Schedule II drugs with misuse potential, yet effective ADHD treatments.
Purpose of the Study:
- To provide an overview of the current challenges with stimulant use in ADHD.
- To outline clinical strategies for preventing and reducing harm associated with stimulant misuse.
- To address the public health implications of increased ADHD diagnoses and stimulant-related mortality.
Main Methods:
- Literature review on ADHD diagnosis trends.
- Analysis of stimulant prescription data and overdose statistics.
- Synthesis of clinical guidelines for safe stimulant management.
Main Results:
- Stimulant misuse, particularly with illicitly manufactured substances containing fentanyl, is a major cause of overdose deaths.
- Effective first-line ADHD treatment with stimulants is challenged by shortages and misuse concerns.
- Urgent need for harm reduction strategies in clinical practice and public health.
Conclusions:
- Clinical strategies are essential to mitigate risks associated with stimulant therapy for ADHD.
- Addressing illicit stimulant use and co-occurring fentanyl exposure is critical.
- Balancing the benefits of stimulant treatment with harm reduction is paramount for patient safety.
More Related Videos
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
10.1K
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
5.6K
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
34
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
34
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
150
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
150
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
88
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
88
01:29Stimulants
156
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
156
01:23Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
01:30Adrenergic Agonists: Therapeutic Uses
712
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
712